| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/20/2011 | US20110014214 Diagnostic and Therapeutic Utility of Tribbles-2 in Human Cancers |
| 01/20/2011 | US20110014209 Recombinant hcv e2 glycoprotein |
| 01/20/2011 | US20110014206 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/20/2011 | US20110014204 Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2 |
| 01/20/2011 | US20110014199 Novel anti-il 13 antibodies and uses thereof |
| 01/20/2011 | US20110014197 Methods of treating pre-eclampsia or eclampsia |
| 01/20/2011 | US20110014187 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014183 Mcam modulation and uses thereof |
| 01/20/2011 | US20110014175 Stimulation of the synthesis of the activity of an isoform of lysl oxidase-like loxl for stimulating the formation of elastic fibres |
| 01/20/2011 | US20110014164 Efficient induction of pluripotent stem cells using small molecule compounds |
| 01/20/2011 | US20110014160 DDR1-Mediated Cell Purification of Pancreatic Endocrine Cells Through Their Progenitors |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014095 Reagent container and reagent set |
| 01/20/2011 | US20110014094 Disk type microfluidic device and blood testing apparatus using the same |
| 01/20/2011 | US20110014086 Method of producing microfluidic device |
| 01/20/2011 | US20110012061 Semiconductor nanocrystal heterostructures |
| 01/20/2011 | US20110012040 Flame safety system for in situ process analyzer |
| 01/20/2011 | US20110011786 Devices For And Methods of Monitoring a Parameter of a Fluidic Sample by Microdialysis |
| 01/20/2011 | US20110011752 Systems and methods for discriminating contorl solution from a physiological sample |
| 01/20/2011 | US20110011742 Method for the purification of biological macromolecules |
| 01/20/2011 | US20110011739 Electrochemical biosensor with sample introduction channel capable of uniform introduction of small amount of sample |
| 01/20/2011 | US20110011738 Test strip with slot vent opening |
| 01/20/2011 | US20110011459 Hybrid and/or complex material, photoelectric conversion material, dye-sensitized solar cell, dye-sensitized solar cell device, manufacturing method of photoelectric conversion device, and method of analyzing titanium oxide crystal structure |
| 01/20/2011 | US20110011161 Method for estimating properties of concrete |
| 01/20/2011 | DE202004021787U1 Tupfer zur Aufnahme von biologischen Proben Swabs for receiving biological samples |
| 01/20/2011 | DE102009032966A1 Vorrichtung zur Behandlung bogenförmiger Substrate mit Licht Apparatus for treating curved substrates with light |
| 01/20/2011 | DE102009032649A1 Massenspektrometrische Identifizierung von Mikroben nach Unterarten Mass spectrometric identification of microbes by subspecies |
| 01/20/2011 | DE102009032502A1 Detektion von Antigenen Detection of antigens |
| 01/20/2011 | DE102009012108A1 Vorrichtung und Verfahren zur Anreicherung und Erfassung von Zellen in strömenden Medien Device and method for the enrichment and detection of cells in flowing media |
| 01/20/2011 | DE102008025127B4 Zustandssensor State sensor |
| 01/20/2011 | CA2842464A1 System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (tcpp) |
| 01/20/2011 | CA2805155A1 Inhibitors of the nitration of amyloid .beta. peptides and their uses in the diagnosis and treatment of alzheimer's disease |
| 01/20/2011 | CA2785431A1 Cleaved and phosphorylated crmp2 as blood marker of inflammatory diseases of the central nervous system |
| 01/20/2011 | CA2778773A1 Devices, methods, and kits for determining analyte concentrations |
| 01/20/2011 | CA2770980A1 Peptides whose uptake in cells is controllable |
| 01/20/2011 | CA2768488A1 Method of assaying 5-fu |
| 01/20/2011 | CA2768475A1 Methods and kits used in assessing cancer risk |
| 01/20/2011 | CA2768371A1 Nucleic acid analysis |
| 01/20/2011 | CA2768352A1 Novel fluorescent dyes and uses thereof |
| 01/20/2011 | CA2768338A1 Method for predicting the utility of administering nicotinic acid or a precursor or prodrug thereof to reduce the severity of side-effects of cancer treatment with nicotinamide phosphoribosyltransferase inhibitors |
| 01/20/2011 | CA2768315A1 A method of analyzing cellulose decay in cellulosic material hydrolysis |
| 01/20/2011 | CA2768247A1 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 01/20/2011 | CA2768106A1 Temperature-compensated in-vivo sensor |
| 01/20/2011 | CA2768013A1 Drug selection for gastric cancer therapy using antibody-based arrays |
| 01/20/2011 | CA2768007A1 Methods of assessing embryo outcome |
| 01/20/2011 | CA2767865A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| 01/20/2011 | CA2767860A1 Serum markers associated with early and other stages of breast cancer |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | CA2767406A1 Flap endonuclease-1 as a marker for cancer |
| 01/20/2011 | CA2766944A1 Analyte testing methods and device for calculating basal insulin therapy |
| 01/20/2011 | CA2766403A1 Diagnostic methods and compositions for treatment of cancer |
| 01/20/2011 | CA2766065A1 Immunoglobulin fc polypeptides |
| 01/20/2011 | CA2763420A1 Mass spectrometric diagnosis of septicemia |
| 01/19/2011 | EP2275821A1 Container |
| 01/19/2011 | EP2275820A1 Diagnostic test strip having fluid transport features |
| 01/19/2011 | EP2275819A2 Method and device for the manipulation of microcarriers for an identification purpose |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275817A1 Proteolytic enzymes in diagnosis of kidney disorders |
| 01/19/2011 | EP2275816A2 Methods for identifying polypeptide targets and uses thereof for treating immunological diseases |
| 01/19/2011 | EP2275815A2 Improved immunoassay methods |
| 01/19/2011 | EP2275814A1 A -oligomer measurement method |
| 01/19/2011 | EP2275813A2 Method for characterising effect yarn |
| 01/19/2011 | EP2275812A1 Apparatus for monitoring mechanical properties of a moving filamentary or planar body and monitoring process |
| 01/19/2011 | EP2275810A1 Sample processing system |
| 01/19/2011 | EP2275809A1 Method of diagnosing pancreatic cancer with the use of n-binding type sugar chains |
| 01/19/2011 | EP2275808A2 Method and apparatus for calibrating electrochemical sensors |
| 01/19/2011 | EP2275807A1 Biosensor for quantifying a substrate |
| 01/19/2011 | EP2275804A1 A method and system for determining the constituent content of a multiphase fluid |
| 01/19/2011 | EP2275802A1 Waveguide grid structure and optical measuring assembly |
| 01/19/2011 | EP2275568A1 Marker sequences for obesity and use of same |
| 01/19/2011 | EP2275567A1 Nucleic acid expression construct and its use as a cell proliferation marker |
| 01/19/2011 | EP2275558A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 01/19/2011 | EP2275555A2 Genetic sequence coding for creatinine deiminase, and its use |
| 01/19/2011 | EP2275554A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275553A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275552A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275551A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275549A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275547A2 Polynucleotides and polypeptide sequences involved in the process of bonne remodeling |
| 01/19/2011 | EP2275544A2 Genes and polypeptides relating to human colon cancers |
| 01/19/2011 | EP2275542A2 Method for identifying useful proteins of brewery yeast |
| 01/19/2011 | EP2275541A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275540A2 Method for controlling the activity of immunologically functional molecule |
| 01/19/2011 | EP2275537A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 01/19/2011 | EP2275534A1 Novel strain of sars-associated coronavirus and applications thereof |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275447A1 Methods of inhibiting metastasis |
| 01/19/2011 | EP2275446A2 Antibodies to insulin-like growth factor I receptor |
| 01/19/2011 | EP2275443A1 Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 01/19/2011 | EP2275442A1 Detection and vizualization of the cell cycle in living cells |
| 01/19/2011 | EP2275438A1 Glucagon-like peptide-2 analogs |
| 01/19/2011 | EP2275435A2 Streptococcus agalactiae antigens I + II |
| 01/19/2011 | EP2275118A2 Pancreas-specific proteins |
| 01/19/2011 | EP2275116A1 Use of a Pak inhibitor for the treatment of a joint disease |
| 01/19/2011 | EP2275075A2 Method of measuring an iron-saccharidic complex |
| 01/19/2011 | EP2275034A1 Blood glucose sensor |
| 01/19/2011 | EP2275033A2 Thin lance and test sensor having same |